XML 57 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION - (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2023
Feb. 28, 2023
Apr. 30, 2022
Jan. 31, 2022
Jul. 31, 2021
Jun. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Apr. 30, 2021
Share-based compensation                  
Stock options granted (in shares)             517,500    
Grant exercise price (in dollars per share)             $ 3.35    
Total compensation expense not yet recognized             $ 2,458,851    
Weighted average vesting period             1 year 3 months 18 days    
Intrinsic value of stock option             $ 251,550,000 $ 5,700,000  
Weighted average grant date fair value             $ 4.33    
June 2021                  
Share-based compensation                  
Share based compensation expense             $ 726,880 726,880  
Stock options granted (in shares)           807,500      
Grant exercise price (in dollars per share)           $ 6.26      
June 2021 | Employee | Tranche one                  
Share-based compensation                  
Vesting percentage           40.00%      
June 2021 | Employee | Tranche two                  
Share-based compensation                  
Vesting term of options           36 months      
July 2021                  
Share-based compensation                  
Share based compensation expense             1,963,667 1,963,667  
Stock options granted (in shares)         1,550,000        
Grant exercise price (in dollars per share)         $ 6.18        
July 2021 | Executive officers | Tranche one                  
Share-based compensation                  
Vesting percentage         25.00%        
July 2021 | Executive officers | Tranche two                  
Share-based compensation                  
Vesting term of options         36 months        
July 2021 | Independent Directors, Consultant                  
Share-based compensation                  
Vesting term of options         36 months        
January 2022                  
Share-based compensation                  
Share based compensation expense             75,800 145,283  
Stock options granted (in shares)       80,000          
Grant exercise price (in dollars per share)       $ 4.44          
January 2022 | Tranche one                  
Share-based compensation                  
Vesting percentage       25.00%          
January 2022 | Tranche two                  
Share-based compensation                  
Vesting term of options       36 months          
April 2022                  
Share-based compensation                  
Share based compensation expense             21,510 $ 35,850  
Stock options granted (in shares)     30,000            
Grant exercise price (in dollars per share)     $ 3.79            
April 2022 | Tranche one                  
Share-based compensation                  
Vesting percentage     25.00%            
April 2022 | Tranche two                  
Share-based compensation                  
Vesting term of options     36 months            
February 2023                  
Share-based compensation                  
Share based compensation expense             365,070    
Stock options granted (in shares)   467,500              
Grant exercise price (in dollars per share)   $ 3.41              
Vesting term of options   36 months              
June 2023                  
Share-based compensation                  
Share based compensation expense             $ 53,600    
Stock options granted (in shares) 50,000                
Grant exercise price (in dollars per share) $ 2.75                
Vesting term of options 1 year                
2021 Equity Incentive Plan                  
Share-based compensation                  
Common stock shares reserved                 2,000,000
Additional common stock shares reserved             465,432    
Common stock shares available (in shares)             485,868